Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 642 matches for

Researchers from the Medical Sciences Division will be running activities on topics from genetic editing to chocolate.

Illustration of a pink head with cables that make shapes of a hand, a test tube and a mobile phone over a yellow background with the name of the festival

What Elio can help teach us about eye patching, stigma and the developing brain

Disney Pixar’s latest film, Elio, follows a familiar-sounding character, a lovable and imaginative young hero who dreams of finding a place where he truly belongs. But amid the colour and chaos of the film’s outer space setting, one subtle detail stands out: Elio wears an eye patch.

Ethnic disparities persist in COVID-19 and cardiovascular disease

A new study has found that people from non-White ethnic backgrounds in England and Wales continued to be disproportionately impacted by severe outcomes after COVID-19 such as cardiovascular disease.

First of its kind study for children with arthritis reveals possible new disease targets

Researchers have been able to see what happens in the inflamed joints of children with arthritis, giving insight into why treatments affect children differently.

New tool allows researchers to track how mutations arise in tissues

Researchers at the MRC Weatherall Institute of Molecular Medicine and the German Cancer Research Center (DKFZ) have developed a new method to analyse how our tissues evolve as we age.

Parkinson’s drug effective in treating persistent depression

A drug used for Parkinson’s disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the University of Oxford.

Oxford to lead new £50m MRC Centre to develop brain stimulation device-based therapies

A new Medical Research Council Centre of Research Excellence (MRC CoRE) aims to develop brain stimulation devices to treat conditions such as Parkinson’s, dementia, stroke and childhood epilepsy.

Academic leaders respond to Medical Research Council call for urgent action on GP research workforce

UK academics call for urgent action to protect the academic GP workforce as government commits £29bn to shift NHS care from hospitals to community. New recommendations aim to safeguard world-leading primary care research.

How do vaccines reduce the risk of dementia?

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how vaccines produce this effect.

‘Single shot’ malaria vaccine delivery system could transform global immunisation

Oxford researchers have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need for booster shots and increasing immunisation coverage in hard-to-reach communities.

Alan Davidson Foundation renews funding for ground-breaking motor neuron disease research at Oxford

As part of its renewed commitment, the Alan Davidson Foundation will continue to fund a full-time project manager to facilitate the ongoing coordination and growth of the ACORN study. The foundation is also contributing to the cost of a research fellow to support the next phase of the project.

Identification of a new metabolic axis underpinning cardiac dysfunction in diabetes

A new publication from Department of Physiology, Anatomy and Genetics identifies a new metabolic axis which explains why the diabetic heart becomes fatty.

Oxford neurosurgeon secures nearly £2 million for brain cancer trial

Associate Professor Puneet Plaha of the Nuffield Department of Surgical Sciences has been awarded a £1.98 million NIHR Health Technology Assessment (HTA) grant to lead a five-year clinical trial addressing one of the most critical questions in brain cancer care.

New consortium to make UK a world leader in AI drug discovery

A new consortium, co-led by NDM researchers, has just been announced, aiming to make the UK a leader in artificial intelligence-driven drug discovery. The ‘OpenBind’ consortium will slash the cost of drug discovery and development by as much as £100 billion.

Early-career researcher wins £1.2 million Wellcome award

Mr Keaton Jones from the Nuffield Department of Surgical Sciences has secured a prestigious Wellcome Early-Career Award worth £1.2 million. His research will investigate the role of macrophages, a type of immune cell, and their metabolism in driving immunotherapy resistance in pancreatic cancer.

New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia

Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.

Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation

The University of Oxford’s vaccine to protect people from deadly Nipah virus has been granted support from the PRIority MEdicines (PRIME) scheme offered by Europe’s medicines regulator, the European Medicines Agency (EMA). It is the first UK academic institution to be awarded this designation.

Malaria vaccine wins Galien Foundation prize for Best Public Sector Innovation

The R21/Matrix-M malaria vaccine has received the Galien Foundation prize for Best Public Sector Innovation. Members of the Jenner Institute team, Prof Sir Adrian Hill, Mehreen Datoo and Lisa Stockdale were present during the Galien Foundation UK Forum & Awards Ceremony in London on 05 June 2025.

Study highlights effectiveness of neuromodulatory therapy on severe epileptic focal seizures

A long-term clinical study has confirmed the effectiveness of a neuromodulatory treatment for severe focal seizures in both children and adults with drug-resistant epilepsy (DRE) and demonstrated the therapy’s lasting impact.

New research identifies key driver of inflammation in spondyloarthritis

NDORMS researchers have identified a primary source of inflammatory IL-17 driving spondyloarthritis, paving the way for the development of targeted therapies to treat the condition.

The Pandemic Sciences Institute publishes first validated tool to measure stigma during disease outbreaks

Researchers at the Pandemic Sciences Institute have published RAPID Stigma Scales to help health professionals monitor stigma in disease outbreak settings, improving outbreak responses globally.

Load More

Similar stories